ClinicalTrials.Veeva

Menu

Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection

A

Ain Shams University

Status

Enrolling

Conditions

Breast Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT06970288
MD45/2025

Details and patient eligibility

About

The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions and avoid using contrast.

Enrollment

85 estimated patients

Sex

Female

Ages

30 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • • Women with suspicious breast mass (BIRADS 4a)

    • High risk women (Positive family history)
    • Women with suspicious axillary lymph nodes by Ultrasound
    • Women with dense breasts coming for MRI imaging.

Exclusion criteria

  • • Contraindications to MRI

    • Pacemaker, cochlear implant, claustrophobia, ocular implants
    • Contraindications to contrast administration:
    • Elevated kidney functions
    • Women who haven't undergone reliable Mammogram & Ultrasound
    • Women with prior treatment or intervention (e.g. biopsy)
    • Patients' refusal.

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed Mohamed Aly

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems